EP Patent

EP2140891B1 — Conduit for coupling to a fluid delivery device

Assigned to Deka Products LP · Expires 2013-03-27 · 13y expired

What this patent protects

A conduit for coupling to a fluid delivery device, the fluid delivery device having a first configuration and a second configuration, the fluid delivery device being an infusion pump having a reservoir with variable volume and a drive assembly, the drive assembly including a barr…

USPTO Abstract

A conduit for coupling to a fluid delivery device, the fluid delivery device having a first configuration and a second configuration, the fluid delivery device being an infusion pump having a reservoir with variable volume and a drive assembly, the drive assembly including a barrel, the conduit comprising: a length of tubing having a first end and a second end; and a hub coupled to the first end for connecting to the fluid delivery device, the hub including a controller for allowing the fluid delivery device to transition from the first configuration to the second configuration, the hub further comprising: a first hub end including a first end face disposed transverse to a hub axis, the first end face including a port disposed along the hub axis, the port having the first end of the length of tubing affixed thereto for passage of fluid from the reservoir, the first end face having formed therein a grip to facilitate rotation of the hub about the hub axis, and a second hub end including a first male element for engaging with a corresponding female element on the reservoir to lock the hub to the reservoir and a second male element for engaging with a corresponding element of the pump housing to retain the reservoir in the barrel when (a) the hub is placed in the pump housing so that the hub axis corresponds with the barrel axis and (b) the hub is rotated; is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2140891B1
Jurisdiction
EP
Classification
Expires
2013-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Deka Products LP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.